Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

This publication has 35 references indexed in Scilit:

• Performance of Delayed-Enhancement Magnetic Resonance Imaging With Gadoversetamide Contrast for the Detection and Assessment of Myocardial Infarction
  Circulation, 2008
• Intracoronary Streptokinase after Primary Percutaneous Coronary Intervention
  New England Journal of Medicine, 2007
• Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
  European Heart Journal, 2007
• Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging
  European Heart Journal, 2006
• Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI
  International Journal of Cardiology, 2005
• Management of microvascular dysfunction and reperfusion injury
  Heart, 2005
• Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging
  European Heart Journal, 2005
• ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary
  Circulation, 2004
• Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts
  American Heart Journal, 2000
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985